HHC
NITE

Hutchin Hill Capital’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Hutchin Hill Capital’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,500
Closed -$240K – 814
2017
Q3 		$240K Buy
+12,500
New +$270K 0.01% 667

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Hutchin Hill Capital's NITE Position: Q4 2017 in Review

Hutchin Hill Capital sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2017, closing a stake of 12,500 shares — an estimated $240K sold.

Hutchin Hill Capital first reported a position in NITE in Q3 2017 and held it in 1 quarter. The position peaked at $240K in Q3 2017. 16 funds tracked by Wall St. Rank hold NITE as of Q4 2017.

  • Hutchin Hill Capital reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 12,500 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2017, an estimated $240K.
  • Hutchin Hill Capital first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 1 quarter.
  • Hutchin Hill Capital's Nightstar Therapeutics plc American Depositary Shares position peaked at $240K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.